Preview Company (Stock code) Date/time Event Presenter
Summit Therapeutics - Initial trials of ridinilazole
SUMMIT THERAPEUTICS (SUMM) Thu, 10 Mar 2016 12:05 pm (UK time) Summit Therapeutics - Initial trials of ridinilazole Mark Wilcox - Professor
Summit Therapeutics - C. difficile Infection, a Recurring Problem
SUMMIT THERAPEUTICS (SUMM) Thu, 10 Mar 2016 12:00 pm (UK time) Summit Therapeutics - C. difficile Infection, a Recurring Problem Mark Wilcox - Professor
32Red - Final Results
32RED (TTR) Thu, 10 Mar 2016 07:05 am (UK time) 32Red - Final Results Ed Ware - Chief Executive
Lombard Risk Management - New global identity and launch of AgileREPORTER
LOMBARD RISK MANAGEMENT (LRM) Wed, 09 Mar 2016 12:05 pm (UK time) Lombard Risk Management - New global identity and launch of AgileREPORTER Alastair Brown - Chief Executive Officer
Forbidden Technologies - Preliminary Results
FORBIDDEN TECHNOLOGIES (FBT) Wed, 09 Mar 2016 09:10 am (UK time) Forbidden Technologies - Preliminary Results Aziz Musa - CEO